Global and Local Epidemiology of Community-Acquired Pneumonia: The Experience of the CAPNETZ Network

Tobias Welte,Thomas Köhnlein

DOI: https://doi.org/10.1055/s-0029-1202941

2009-03-18

Seminars in Respiratory and Critical Care Medicine

Abstract:Community-acquired pneumonia (CAP) is a major cause of morbidity and mortality worldwide. Young children and the elderly are disproportionately affected by CAP. Lower respiratory tract infections (LRTIs), including CAP, were ranked third in a list of the 30 leading causes of death worldwide in 1990. Mortality rates are low (< 2%) in CAP patients treated as outpatients, but are higher (5 to 20%) among patients hospitalized for CAP, and are highest (up to 50%) in patients admitted to the intensive care unit. Several risk factors are known to be associated with increases in mortality, the most important of which are age > 65 years, male gender, and comorbidities such as chronic heart failure, advanced chronic obstructive pulmonary disease, neurological diseases, and liver cirrhosis. Patients living in nursing homes may have a special risk for multiresistant bacterial infection. The incidence of CAP varies worldwide by country, age, and gender. Further, data about epidemiology, etiology, morbidity, mortality, and economical burden of diseases differ between countries. In this review, we present recent data regarding the incidence, etiology, and rate of antibiotic resistance among CAP patients from the German Network for Community Acquired Pneumonia (CAPNETZ) registry and review data from several European countries.

respiratory system,critical care medicine

What problem does this paper attempt to address?

The problems that this paper attempts to solve mainly focus on the global and regional epidemiological characteristics of community - acquired pneumonia (CAP). Specifically, the research aims to explore the following aspects:

1. **Incidence**: Study the differences in the incidence of CAP among different countries, age groups and genders. For example, the paper points out that as age increases, the incidence of CAP increases significantly, and the incidence in men is higher than that in women. In addition, there are also differences in the incidence of CAP among different countries.

2. **Etiology**: Explore the main pathogens causing CAP and their distribution. Research shows that although there are a large variety of pathogens, Streptococcus pneumoniae is one of the most common pathogens and may account for more than 50% of all CAP cases.

3. **Antibiotic resistance**: Analyze the frequency of antibiotic resistance in CAP patients and its impact. The paper mentions that the resistance of Streptococcus pneumoniae to β - lactam antibiotics is an important issue, especially for those patients who have used antibiotics within the last three months.

4. **Mortality and related risk factors**: Evaluate the mortality of CAP patients and identify the risk factors associated with high mortality. The study found that the mortality rate of CAP patients hospitalized is relatively high, especially for those admitted to the intensive care unit (ICU), with a mortality rate of up to 50%. Being over 65 years old, male, having comorbidities such as chronic heart failure, chronic obstructive pulmonary disease (COPD), neurological diseases and liver cirrhosis are important risk factors for high mortality.

5. **Economic burden**: Evaluate the socioeconomic impact of CAP, including medical costs and indirect costs due to absence from work due to illness. For example, the cost of CAP treatment in the United States is estimated to be $8 billion annually, most of which is for the elderly and hospitalized patients.

Through these studies, the paper aims to provide a scientific basis for the prevention, diagnosis and treatment of CAP, thereby reducing its incidence and mortality and alleviating the socioeconomic burden.